3Stasi R, Brunettim, Terzoli E, et al. Sustained response to recombinant human erythropoietin and intermittent all-trans retinoic acid in patients with myelodysplastic syndromes. Blood, 2002, 99: 1578-1584.
二级参考文献32
1Fabian I, Shvartzmayer S, Fibach E. Induction of morphological and functional differentiation of human myeloid leukemia cells (HL-60 and LK) by a benzoic acid derivative of retinoic acid. Leuk Res,1987; 11:863- 868
2Hebbar M, Kaplan C, Caulier MT, et al. Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to
3Shibakura M, Niiya K, Kiguchi T, et al. Simultaneous induction of matrix metalloproteinase-9 and interleukin 8 by all-trans retinoic acid in human PL-21 and NB4 myeloid leukaemia cells. Br J Haematol,2002; 118:419 - 425
4Stadtmauer EA, Cassileth PA, Edelstein M, et al. Danazol treatment of myelodysplastic syndrome. Br J Haemetol, 1991; 77:502 -508
5Chan GW, Divenuti G, miller K. Danazol for the treatment of thrombocytopenia in myelodysplastic Syndromes(abstract). Blood,2000; 96:147a
6Kurzrock R, Estey E, Talpaz M. All-trans retinoic acid: tolerance and biologic effect in myelodysplastic syndrome. J Clin Oncol,1993; 11:1489- 1495
7Hast R, Beksac M, Axdorph S, et al. Effects of retinoids on in vitro differentiation of bone marrow cells in the myelodysplastic syndrome. Med Oncol Tumor Pharmacother, 1986; 3:35- 38
8Letendre L, Levitt R, Pierre RV, et al. Myelodysplasic syndrome treatment with danazol and cis-retinoic acid. Am J Hematol, 1995;48:233 - 236
9Bowen DT. Oxidative stress and the myelodysplastic syndromes.Leuk Res, 2000; 24:139 -140
10Selleri C, Catalano L, De-Rosa G, et al. Danazol: in vitro effects on human hemopoiesis and in vivo activity in hypoplastic and myelodysplastic disorders. Eur J Haematol, 1991; 47:197 - 203
